MOUNTAIN VIEW, Calif.,
Nov. 30, 2016 /PRNewswire/ --
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication
management and supply chain solutions for healthcare systems and
pharmacies, and Hospira, a Pfizer (NYSE:PFE) company and a leading
provider of infusion technologies, today announced they have
achieved initial interoperability between Omnicell's new
Performance Center and Hospira's smart infusion pumps.
Users of the Performance Center, an integrated services and
software platform designed to drive improved pharmacy operations
through long-term partnerships with customers, can now directly
access Hospira MedNet Safety Software, which can help
enhance patient safety through the management and enforcement of
drug-specific dosing limits on IV medications. The ability to
directly connect with Hospira MedNet from Omnicell's Performance
Center enables streamlined access to drug libraries and IV
administration reporting for nurses and pharmacists at hospitals
utilizing both technologies.
In addition, Omnicell and Hospira announced that the two
companies are collaborating to further system interoperability,
with the goal of delivering the greatest possible value to the
hundreds of hospitals that utilize Omnicell's medication management
solutions and Hospira's infusion technologies.
"This initial step in integrating Hospira MedNet Safety Software
and the Omnicell Performance Center is an important advancement
toward greater interoperability between two innovative
technologies," said Julie Sawyer
Montgomery, president, Hospira Infusion Systems. "We
are excited to be collaborating with Omnicell towards
interoperability opportunities to support healthcare organizations
seeking measurable improvement in clinician workflow, patient
satisfaction and medication management."
"Many of our customers have expressed a desire for a central
location to review clinical data from disparate pharmacy systems,"
said Nhat Ngo, executive vice
president, Strategy and Business Development, Omnicell. "Working
closely with Hospira to provide such a solution for pharmacy
through the Performance Center is an important step that will
bolster what we can offer to our customers."
For more information, please visit the Omnicell booth (#420) and
Hospira booth (#243) at the 2016 ASHP Midyear Clinical Meeting and
Exhibition at the Mandalay Bay Convention Center in Las Vegas from December
5-7.
About Hospira
Hospira, a Pfizer company, is a leading provider of infusion
technologies. The company's focused infusion systems portfolio
features I.V. solutions, proven, innovative smart pumps, and pain
management and safety software technology designed to help meet
clinical, safety and workflow goals. Learn more at
www.hospira.com.
About Omnicell
Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create
safer and more efficient ways to manage medications and supplies
across all care settings. As a leader in medication and supply
dispensing automation, central pharmacy automation, IV robotics,
analytics software, and medication adherence and packaging systems,
Omnicell is focused on improving care across the entire healthcare
continuum—from the acute care hospital setting, to post-acute
skilled nursing and long-term care facilities, to the patient's
home.
Over 4,000 customers worldwide use Omnicell®
automation and analytics solutions to increase operational
efficiency, reduce medication errors, deliver actionable
intelligence and improve patient safety. The recent acquisition of
Aesynt adds distinct capabilities, particularly in central pharmacy
and IV robotics, creating the broadest medication management
product portfolio in the industry.
The Omnicell SureMed® solution provides innovative
medication adherence packaging to help reduce costly hospital
readmissions. These medication adherence solutions are used by over
17,000 institutional and retail pharmacies in North America and the United Kingdom. These pharmacies are
served via Omnicell's sales channels and our solutions enable them
to maintain high accuracy and quality standards in medication
dispensing and administration while optimizing productivity and
controlling costs.
For more information about Omnicell, Inc. please visit
www.omnicell.com.
OMCL-G
Logo - http://photos.prnewswire.com/prnh/20161130/444313LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/omnicells-performance-center-integrates-with-hospiras-infusion-pump-software-300370807.html
SOURCE Omnicell, Inc.